ResMed, Inc. (RMD) Tops Q2 EPS by 2c

ResMed, Inc. (NYSE: RMD) reported Q2 EPS of $0.53, $0.02 better than the analyst estimate of $0.51. Revenue for the quarter came in at $376.5 million versus the consensus estimate of $363.76 million.

For earnings history and earnings-related data on ResMed, Inc. (RMD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Burry doubles down on Nebius short after stock surges 34% on earnings
• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Innovative Solutions & Support (ISSC) Tops Q3 EPS by 10c